Vetter Pharma stock price, funding rounds, valuation and financials

Vetter Pharma annual revenue was €594.95 m in FY 2018

€594.9 M

Vetter Pharma Revenue FY, 2018
Vetter Pharma Revenue growth (FY, 2017 - FY, 2018), %6%
Vetter Pharma Cash, 31-Dec-20183.9 M
Get notified regarding key financial metrics and revenue changes at Vetter PharmaLearn more
Banner background

Vetter Pharma Funding

Summary Metrics

Founding Date

1950

Vetter Pharma Income Statement

Annual

EURFY, 2016FY, 2017FY, 2018

Revenue

503.2m562.1m594.9m

Revenue growth, %

12%6%

General and administrative expense

228.5m253.2m265.6m

Operating expense total

228.5m253.2m265.6m

Vetter Pharma Balance Sheet

Annual

EURFY, 2016FY, 2017FY, 2018

Cash

9.0m1.7m3.9m

Accounts Receivable

90.8m107.4m107.8m

Prepaid Expenses

1.8m2.4m2.7m

Inventories

85.1m81.6m91.1m

Current Assets

203.3m213.9m223.7m

PP&E

365.3m459.2m549.2m

Total Assets

572.4m676.5m785.9m

Accounts Payable

23.8m22.6m21.3m

Long-term debt

182.0m246.8m315.8m

Total Debt

182.0m246.8m315.8m

Total Liabilities

322.7m381.7m472.4m

Total Equity

249.7m294.8m313.5m

Debt to Equity Ratio

0.7 x0.8 x1 x

Debt to Assets Ratio

0.3 x0.4 x0.4 x

Financial Leverage

2.3 x2.3 x2.5 x

Vetter Pharma Ratios

EURFY, 2016

Revenue/Employee

134.9k

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.3 x

Vetter Pharma Operating Metrics

FY, 2016FY, 2017FY, 2018

New Drugs Approved (EU)

2845

New Drugs Approved (Germany)

3136

New Drugs Approved (USA)

224659

Vetter Pharma Employee Rating

3.829 votes
Culture & Values
3.4
Work/Life Balance
3.2
Senior Management
3.3
Salary & Benefits
3.5
Career Opportunities
3.7
Source